The European Medicines Agency says it will begin reviewing data to decide if a smallpox vaccine made by the pharmaceutical company Bavarian Nordic might also be authorized for monkeypox.
FILE - This 2003 electron microscope image made available by the Centers for Disease Control and Prevention shows a monkeypox virion, obtained from a sample associated with the 2003 prairie dog outbreak. The U.S. government is building up its supply of monkeypox vaccine to contend with escalating cases identified in a surprising international outbreak, health officials said Friday, June 10, 2022.
“The decision to start this review is based on results from laboratory studies suggesting that the vaccine triggers the production of antibodies that target the monkeypox virus,” the EMA said. The regulator said that supplies of the vaccine are currently very limited in Europe.According to the U.S.
Britain, which has the biggest outbreak beyond Africa, recently widened its vaccination policy to those at highest risk of monkeypox, which it defined as “gay and bisexual men at higher risk of exposure,” meaning those who have “multiple partners, participate in group sex or attends ‘sex on premises’ venues.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
EU begins review of Bavarian Nordic's vaccine for monkeypoxEU drug regulators are reviewing the use of Bavarian Nordic's smallpox vaccine to prevent monkeypox disease. The shot is cleared in the U.S. to treat both smallpox and monkeypox.
Lire la suite »
New monkeypox case reported in N.J. as US officials announce more steps against outbreakHealth officials have expanded the group of people recommended to get vaccinated against the monkeypox virus.
Lire la suite »